Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
Vivian Tang, Rufei Lu, Kanish Mirchia, Jessica Van Ziffle, Patrick Devine, Julieann Lee, Joanna J. Phillips, Arie Perry, David R. Raleigh, Calixto‐Hope G. Lucas, David A. Solomon
Topics & Concepts
CDKN2ACancer researchPathologyMedicineBiologyGeneticsCancerMeningioma and schwannoma managementGlioma Diagnosis and TreatmentHead and Neck Surgical Oncology